About SYTABZ MEDITECH
SYTABZ MEDITECH is a Healthcare company. Pharmaceutical formulation, development, and manufacturing services are provided in Bengaluru. It operates in the Healthcare and Industrial Goods & Manufacturing sectors. Its Indian entity Sytabz Meditech Private Limited reported revenue of ₹77.9 Lakh. SYTABZ MEDITECH offers products and services including Pharmaceutical Products and WHO-GMP Certified Manufacturing. Its focus areas include Pharmaceuticals, Formulation and Development, Innovative Product Launching and Manufacturing.
Company details
Sytabz Meditech is recognized as a Bengaluru-based pharmaceutical company that specializes in formulation and development, with a focus on launching niche innovative products. Products are manufactured at WHO-GMP certified plants to guarantee quality and efficacy, ensuring they are affordable and accessible to various patient sectors. The companys mission emphasizes the provision of quality products aimed at complete wellbeing, supported by experienced teams in medical, marketing, and sales. This approach is maintained to cater effectively to market needs while upholding standards of compliance and innovation.
- SectorsHealthcareIndustrial Goods & Manufacturing
- Email••••••••
- Legal Name Sytabz Meditech Private Limited
- Date of Incorporation 30 May, 2018
- Jurisdiction Bangalore, Karnataka, India
- Indian entity revenue₹77.9 Lakh
FY 2024 · +22% YoY
- Indian entity net loss-₹50.7 Lakh
FY 2024 · -65% margin
- Indian entity EBITDA-₹26 Lakh
FY 2024 · -33% margin
Associated legal entities of SYTABZ MEDITECH
SYTABZ MEDITECH operates through Sytabz Meditech Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Sytabz Meditech Private Limited CIN U33100KA2018PTC113549 | Active | 30 May 2018 | Bangalore, Karnataka | ₹0.8 Cr | 5 | View details |
Products & Services of SYTABZ MEDITECH
SYTABZ MEDITECH offers a comprehensive portfolio of products and services, including Pharmaceutical Products and WHO-GMP Certified Manufacturing.
Niche innovative products are developed and launched by the company.
Products are manufactured at certified plants to ensure quality and efficacy.
Board of directors of Sytabz Meditech Private Limited (SYTABZ MEDITECH)
Sytabz Meditech Private Limited is the primary company behind SYTABZ MEDITECH. The board of Sytabz Meditech Private Limited currently have 5 directors; the longest-serving is Addekoppa Chikkananjundaiah Ramesh, appointed in 2018. 5 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Addekoppa Chikkananjundaiah Ramesh DIN 08146142 | Director | 30 May 2018 | 8 yrs 5 mo | Sytabz Meditech Private Limited |
| Suma Rani Krishnamurthy DIN 08146143 | Director | 30 May 2018 | 8 yrs 5 mo | Sytabz Meditech Private Limited |
| Gurukrupa Vasudeva Rao DIN 08432022 | Director | 01 Aug 2018 | 8 yrs 2 mo | Sytabz Meditech Private Limited |
| Rajeeva Shankaranarayana Rao Lakshmi Kanthan DIN 08028929 | Director | 23 Nov 2018 | 7 yrs 11 mo | Sytabz Meditech Private Limited |
| Deeksha Nagaraju DIN 09289271 | Director | 25 Aug 2021 | 5 yrs 2 mo | Sytabz Meditech Private Limited |
Financials of SYTABZ MEDITECH
Figures of Sytabz Meditech Private Limited, the primary company behind SYTABZ MEDITECH, for FY 2024. Revenue was ₹77.9 Lakh (+22% year on year). Net loss was -₹50.7 Lakh (-65% margin). EBITDA was -₹26 Lakh (-33% margin). Revenue has grown at a compounded annual rate of +63% over three years and +27% over five years.
- ₹77.9 LakhRevenue · FY 2024 · +22% YoY
- -₹50.7 LakhNet loss · -65% margin
- -₹26 LakhEBITDA · -33% margin
- ₹3 LakhPaid-up capital
- +63%Revenue CAGR, 3 years
- +27%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Sytabz Meditech Private Limited are on its company page.
Detailed financial statements for SYTABZ MEDITECH
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about SYTABZ MEDITECH
The primary company behind SYTABZ MEDITECH, Sytabz Meditech Private Limited, reported revenue of ₹77.9 Lakh for FY 2024, up 22% year on year.
Sytabz Meditech is recognized as a Bengaluru-based pharmaceutical company that specializes in formulation and development, with a focus on launching niche innovative products. Products are manufactured at WHO-GMP certified plants to guarantee quality and efficacy, ensuring they are affordable and accessible to various patient sectors. The companys mission emphasizes the provision of quality products aimed at complete wellbeing, supported by experienced teams in medical, marketing, and sales. This approach is maintained to cater effectively to market needs while upholding standards of compliance and innovation.
SYTABZ MEDITECH offers Pharmaceutical Products and WHO-GMP Certified Manufacturing.
SYTABZ MEDITECH operates through Sytabz Meditech Private Limited.
The legal entities of SYTABZ MEDITECH currently have 5 directors, including Gurukrupa Vasudeva Rao, Deeksha Nagaraju, Addekoppa Chikkananjundaiah Ramesh and others.